Amgen 2015 Annual Report Download - page 83

Download and view the complete annual report

Please find page 83 of the 2015 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

F-5
AMGEN INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
Years ended December 31, 2015, 2014 and 2013
(In millions)
Number
of shares
of common
stock
Common
stock and
additional
paid-in capital
Accumulated
deficit
Accumulated
other
comprehensive
income (loss) Total
Balance at December 31, 2012 756.3 $ 29,337 $ (10,423) $ 146 $ 19,060
Net income — 5,081 — 5,081
Other comprehensive loss, net of tax ———
(307)(307)
Dividends ——
(1,521)—
(1,521)
Issuance of common stock in connection
with the Company’s equity award
programs 7.4 296 — 296
Stock-based compensation — 400 — 400
Settlement of conversion value of
convertible debt in excess of principal (99)— —(99)
Settlement of convertible note hedge —99——99
Settlement of warrants (100)— —
(100)
Tax impact related to employee stock-based
compensation (42)— —(42)
Repurchases of common stock (9.1) (771)—
(771)
Balance at December 31, 2013 754.6 29,891 (7,634)(161) 22,096
Net income — 5,158 — 5,158
Other comprehensive income, net of tax — 153 153
Dividends ——
(1,995)—
(1,995)
Issuance of common stock in connection
with the Company’s equity award
programs 6.7 186 — 186
Stock-based compensation — 404 — 404
Tax impact related to employee stock-based
compensation (71)— —(71)
Repurchases of common stock (0.9) (153)—
(153)
Balance at December 31, 2014 760.4 30,410 (4,624)(8) 25,778
Net income — 6,939 — 6,939
Other comprehensive loss, net of tax ———
(472)(472)
Dividends ——
(2,548)—
(2,548)
Issuance of common stock in connection
with the Company’s equity award
programs 5.682——82
Stock-based compensation — 319 — 319
Tax impact related to employee stock-based
compensation (162)— —
(162)
Repurchases of common stock (12.0) (1,853)—
(1,853)
Balance at December 31, 2015 754.0 $ 30,649 $ (2,086)$ (480) $ 28,083
See accompanying notes.